Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases
Clinical Microbiology Reviews · 11.09.2025 · 38 (3)
DOI: 10.1128/cmr.00129-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 11.09.2025. Verfasst von Rémy A Bonnin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT/UMRS1184), Font…. Hauptthemen laut MEDLINE: beta-Lactamases, Genetic Variation, Bacterial Proteins, Gram-Negative Bacteria. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 369 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Metallo-beta-lactamases are an ever-growing problem. Since the discovery of the beta-lactamase of Bacillus cereus in the late 1960s, many class B beta-lactamases have been reported, with three main families being NDM-, IMP-, and VIM-like. IMP- and VIM-like carbapenemases have been identified in a wide variety of Gram-negative bacteria. VIM-type carbapenemases are widely distributed, primarily represented by two main clusters, VIM-1 and VIM-2, and have been found in both Enterobacterales and non-fermenters. IMP-type carbapenemases are characterized by a significant genetic diversity and low identity between subgroups. This carbapenemase is more prevalent in Asia but has been identified globally, in both Enterobacterales and non-fermenters, as observed for VIM-type carbapenemases. The genetic diversity of IMP- and some VIM-type carbapenemases limits their detection. This review aims to discuss the genetic diversity, epidemiology, and biochemical characteristics of VIM- and IMP-type carbapenemases. It also evaluates the efficacy of commercially available detection tests and the in vitro activity of recently developed inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
- Associated French National Reference Center for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Le Kremlin-Bicêtre, France.
- Bacteriology-Hygiene Unit, Assistance Publique-Hôpitaux de Paris, AP-HP Paris Saclay, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
ORCID-Profile: Rémy A Bonnin, Cécile Emeraud, Thierry Naas, Laurent Dortet
Zitieren
APA
Bonnin, R. A., Jousset, A. B., Jacquemin, A., Emeraud, C., Girlich, D., Naas, T., & Dortet, L. (2025). Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases. Clinical Microbiology Reviews, 38(3). https://doi.org/10.1128/cmr.00129-23
Vancouver
Bonnin RA, Jousset AB, Jacquemin A, Emeraud C, Girlich D, Naas T, et al. Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases. Clinical Microbiology Reviews. 2025;38(3). doi:10.1128/cmr.00129-23
BibTeX
@article{Bonnin2025,
author = {Bonnin, Rémy A and Jousset, Agnès B and Jacquemin, Aymeric and Emeraud, Cécile and Girlich, Delphine and Naas, Thierry and Dortet, Laurent},
title = {Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases},
journal = {Clinical Microbiology Reviews},
year = {2025},
volume = {38},
number = {3},
doi = {10.1128/cmr.00129-23}
}
EUVIMED